PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 21 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A preparation of plantago seeds and senna pods resulted in normalization of gastrointestinal transit time in 88% of patients (n=100) over 3 months [PMID:2955623].
A combination of senna pods and Goleytely solution was found to be almost identical to the exclusive ingestion of 7 litres of Goleytely solution in terms of visual assessment scores and intestinal gases (n=80) [PMID:1912715].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 8234429 (1993) — The senna drug and its chemistry. · Pharmacology
- 2.PMID: 8234447 (1993) — Metabolism and pharmacokinetics of anthranoids. · Pharmacology
- 3.PMID: 12278407 (1979) — Medicinal plants make a comeback. · The Unesco courier
- 4.PMID: 37639733 (2023) — Inhibitory effects of epiphytic Kluyveromyces marxianus from Indian senna (Cassia angustifolia Vahl.) on growth and aflatoxin production of Aspergillus flavus. · International journal of food microbiology
- 5.PMID: 39318338 (2025) — Aflatoxin B1 in senna pods from field to storage in Tamil Nadu, India. · Food additives & contaminants. Part B, Surveillance